Biomarin Pharmaceutical Inc 10-Q for FY2020 Q2
Biomarin Pharmaceutical Inc (BMRN)
10-Q
2020-08-05
For: 2020-06-30
View Original
Added on
April 12, 2026
About this 10-Q
Biomarin Pharmaceutical Inc filed this 10-Q on August 5, 2020, covering the quarter ended June 30, 2020 (FY2020 Q2).
Headline figures
Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $429.49M
- up 10.8% from $387.76M a year earlier
- Net loss
- $29.18M
- compared with a net loss of $37.44M a year earlier
- Diluted EPS
- -$0.16
- compared with -$0.21 a year earlier